Concepts of topical steroid therapy

Research and Clinical Forums

Volumn 18, Issue 1, 1996, Pages 56-65

  Brattsand, R ^a  

^a Preclinical Research and Development   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; PREDNISOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; CHEMICAL STRUCTURE; CONFERENCE PAPER; DISSOLUTION; DRUG ABSORPTION; DRUG CLEARANCE; DRUG EFFICACY; DRUG UPTAKE; ENTERITIS; HUMAN; HYDROPHILICITY; INTESTINE FLUID; INTESTINE MUCOSA; LIVER BLOOD FLOW; MEAN RESIDENCE TIME; METABOLIC CLEARANCE RATE; NONHUMAN; PROCTITIS; RECEPTOR AFFINITY; STEROID THERAPY; STRATUM CORNEUM; TOPICAL DRUG ADMINISTRATION;

EID: 0029864623     PISSN: 01433083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. BRATTSAND, R. and SELROOS, O. Glucocorticosteroids. In: Drugs and the lung (Eds. C.P. Page and W.J. Metzger), Raven Press Ltd, New York, 1994; pp 101-220.
2. HAYNES, R.C. Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: The pharmacological basis of therapeutics (Eds. A. Goodman-Gilman, T.W. Rall, A.S. Nies and P. Taylor). 8th ed. Pergamon Press, New York, 1990; pp 1411-1462.
3. Corticosteroid treatment in allergic airway diseases. (Eds. T.J.H. Clark, N. Mygind and O. Selroos). Eur. J. Respir. Dis., 1982; 63 (Suppl. 122): 7-278.
4. TRUELOVE, S. Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium: a report on a controlled therapeutic trial. Br. Med. J., 1958; 2: 1072-1077.
5. WATKINSON, G. Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate: a controlled trial employing restricted sequential analysis. Br. Med. J., 1958; 2: 1077-1082.
6. BRATTSAND, R.L. Overview of newer glucocorticosteroid preparations for inflammatory bowel disease. Can. J. Gastroenterol., 1990; 4: 407-414
7. BRATTSAND, R.L. Steroid development: a case of enhanced selectivity for the bowel wall. In: Reviewing steroids in the treatment of IBD (Eds. D.P. Jewell and P. Rutgeerts). Res. Clin. Forum., 1993; 15(5): 17-33.
8. LÖFBERG, R. New steroids for inflammatory bowel disease. Inflamm. Bowel Dis., 1995; 1: 135-141.
9. FARMER, G. and SCHUMACHER, O.P. Treatment of ulcerative colitis with hydrocortisone: absorption, adrenal suppression and clinical response. Dis. Col. Rectum., 1970; 13: 355-361.
10. CANN, P.A. and HOLDSWORTH, C.D. Systemic absorption from hydrocortisone foam enema in ulcerative colitis. Lancet, 1987; 22: 987-992
11. DANIELSSON, Å., HELLERS, G., LYRENÀS, E., LÖFBERG, R., NILSSON, A., OLSSON, O., OLSSON, S.Å., PERSSON, T., SALDE, L., NAESDAL, J., STENSTAM, M. and WILLE'N, R.A. A Controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Scand. J. Gastroenterol., 1987; 22: 987-992.
12. MARTIN, L.E., TANNER, R.J.N., CLARK, T.J.H. and COCHRANE, G.M. Absorption and metabolism of orally administered beclomethasone dipropionate. Clin. Pharmaco. Ther., 1974, 15: 267-275.
13. MORROW-BROWN, H. The introduction and early development of steroid therapy. In: Topical steroid treatment for asthma and rhinitis (Eds. N. Mygind and T.J.H. Clark). Balliere Tindall, London, 1980; pp 66-76.
14. BRATTSAND, R., THALE'N, A., ROEMPKE, K., KÄLLSTRÖM, L. and GRUVSTAD, E. Influence of 16alpha, 17alpha-acetal substitution and steroid nuclear fluorination on the topical to systemic activity ratio of glucocorticoids. J. Steroid Biochem., 1982; 16: 779-786.
15. BROGDEN, R.N. and MCTAVISH, D. Budesonide. An updated review of its pharmacological properties and therapeutic efficacy in asthma and rhinitis. Drugs, 1992; 44(3): 375-407.
16. Reviewing steroids in the treatment of IBD. (Eds. D.P. Jewell and P. Rutgeerts). Res. Clin. Forum., 1993; 15(5): 7-103.
17. JEWELL, D.P. Corticosteroids for the management of ulcerative colitis and Crohn's disease. Gastroenterol. Clin. North. Am., 1989; 18: 21-34.
18. MRYERS, S. and SACHAR, D.B. Medical management of Crohn's disease. Hepatogastroenterology, 1990; 37: 42-55.
19. WRIGHT, J.P., JARNUM, S., SCAFFALITZKY DEMUCKADELL, O., KEECH, M.L. and LENNARD-JONES, J.E. Oral fluticasone propionate compared with prednisolone in treatment of active Crohn's disease: a randomized double-blind multicentre study. Eur. J. Gastroenterol. Hepatol., 1993; 5: 499-503.
20. ANOUS, P., SNOOK, J.A., REID, M. and JEWELL, D.P. Oral fluticasone propionate in active distal ulcerative colitis. Gut, 1992; 33: 711-714.
21. HAWTHORNE, A.B., RECORD, C.O., HOLDSWORTH, C.D. GIAFFER, M.H., BURKE, D.A., KEECH, M.L. and HAWKEY, C.J. Double blind trial of oral fluticasone propionate vs prednisolone in the treatment of active ulcerative colitis. Gut, 1993; 34: 125-128.
22. MILLER-LARSSON, A., GUSTAFSSON, B., BRATTSAND, R. and PERSSON, C.G.A. Mucosal uptake and retention of steroids in rat ileum: possible explanation of topical efficacy in inflammatory bowel disease. Gastroenterology, 1995; 108: A876.
23. CAMPIERI, M., FERGUSON, A., DOE, W. and THE INTERNATIONAL BUDESONIDE STUDY GROUP. Oral budesonide compares favourably with prednisolone in active Crohn's disease. Gastroenterology, 1995; in press.
24. DAHLBERG, E., THALE'N, A., BRATTSAND, R., GUSTAFSSON, J.A., JOHANSSON, U., ROEMPKE, K. and SAARTOK, T. Correlation between chemical structure, receptor binding and biological activity of some novel, highly active, 16alpha, 17alpha-acetal-substituted glucocorticoids. Mol. Pharmacol., 1984; 25: 70-78.
25. EDSBÄCKER, S., JÖNSSON, S., LINDBERG, C., RYRFELDT, Å. and THALE'N, A. Metabolic pathways of the topical glucocorticoid budesonide in man. Drug Metabol. Dispos., 1983; 11: 590-596.
26. EDSBÄCKER, S., ANDERSSON, P., LINDBERG, C., RYRFELDT, Å. and THALE'N, A. Metabolic acetal splitting of budesonide - A novel inactivation pathway for topical glucocorticoids. Drug Metabol. Dispos., 1987; 15: 412-417.
27. EDSBÄCKER, S., ANDERSSON, P., LINDBERG, C., PAULSSON, J., RYRFELDT, Å. and THALE'N, A. Liver metabolism of budesonide in rat, mouse and man. Comparative aspects. Drug Metabol. Dispos., 1987; 15: 403-411.
28. JÖNSSON, G., ÅSTRÖM, A. and ANDERSSON, P. Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver. Drug. Metabol. Dispos., 1995; 23: 137-142.
29. RYRFELDT, Å., ANDERSSON, P., EDSBÄCKER, S., TÖNNESSON, M., DAVIES, D. and PAUWELS, R. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur. J. Respir. Dis., 1982; 63 (Suppl. 122): 86-95.
30. EDSBÄCKER, S., DAHLSTRÖM, K. and CONRADSSON, T-B. Rectal and oral bioavailability of budesonide in man. Hellenic J. Gastroenterol., 1992; 5: 75.
31. GUSTAFSSON, B. and PERSSON, C.G.A. Allergen-induced mucosal exudation of plasma in rat ileum and its inhibition by budesonide. Scand. J. Gastroenterol, 1992; 27: 587-593.
32. GUSTAFSSON, B. and PERSSON, C.G.A. Oral budesonide exhibits greater topical selectivity than prednisolone in a rat ileal inflammation model. Gastroenterology, 1994; 106(4): A696.
33. GUSTAFSSON, B., MILLER-LARSSON, A., BRATTSAND, R. and PERSSON, C.G.A. Onset of action and topical anti-inflammatory efficacy of budesonide in allergen challenged rat ileum. Gastroenterology, 1995; 108(4): A830.
34. FABIA, R., AR'RAJAB, A., WILLE'N, R., BRATTSAND, R., ERLANSSON, M. and SVENSJÖ, E. Topical anticolitic efficacy and selectivity of the glucocorticoid budesonide in a new model of acetic acid-induced acute colitis in the rat. Aliment. Pharmacol. Ther., 1994; 8: 433-446.
35. JACOBSON, K., MCHUGH, K., SVENSJÖ, E., BRATTSAND, R. and COLLINS, S. Budesonide enemas prevent extensive changes in the enteric nervous system in rats with experimental colitis. Gastroenterology, 1993; 104(4): A718.
36. VANREES, E.P., SOETYO, M., PALMEN, M.H.J.H., PENA, S. and MEUWISSEN, S.G.M. Effect of local budesonide treatment in experimental inflammatory bowel disease. Gastroenterology, 1993; 104(4): A795.
37. DANIELSSON, Å. Clinical experience of a new topical steroid, budesonide, for the effective management of ulcerative colitis. In: Reviewing steroids in the treatment of IBD (Eds. D.P. Jewell and P. Rutgeerts), Res. Clin. Forum., 1993; 15(5): pp 64-73.